ICON early Phase Services LLC

San Antonio, Texas 78232

4 studies enrolling now · 26 studies all time

What they study most

Acute Kidney Injury, Atopic Disease, Autoimmune Disease, Bacterial Vaginosis, Diabetes Mellitus, Type 2, Healthy, Healthy Participants, Healthy Subjects, Healthy Volunteers, Kidney Diseases, NAFLD, Obesity

Studies at this site

• A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants — Recruiting now
• A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy — Recruiting now
• Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) — Recruiting now
• A Study on How NNC0174-1213 Works in People With Overweight or Obesity. — Recruiting now
• Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole — Completed
• Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults — Stopped early
• Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease — Completed
• A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin — Completed
• NasoShield Study of Safety and Immunogenicity — Completed
• A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity — Completed
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets — Completed
• Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 — Completed
• Voxelotor CYP and Transporter Cocktail Interaction Study — Completed
• Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects — Completed
• DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. — Completed
• A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity — Completed
• Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route — Status unconfirmed
• A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants — Completed
• Safety, Tolerability and PK of a Single Subcutaneous Injection of XmAb27564 in Healthy Volunteers — Completed
• A Study to Assess S-309309 in Healthy and Obese Participants — Completed
• Pharmacokinetic Study of DARE-BV1 — Completed
• Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults — Completed
• Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites — Completed
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ — Completed
• Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195 — Completed
• A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects — Completed